SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-09-009714
Filing Date
2009-11-06
Accepted
2009-11-06 13:15:30
Documents
1
Period of Report
2009-12-16
Effectiveness Date
2009-11-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2195252zdef14a.htm DEF 14A 580948
  Complete submission text file 0001047469-09-009714.txt   582577
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 091163790
SIC: 2835 In Vitro & In Vivo Diagnostic Substances